Author/Authors :
Tanabe، نويسنده , , Kengo and Hoye، نويسنده , , Angela and Lemos، نويسنده , , Pedro A and Aoki، نويسنده , , Jiro and Arampatzis، نويسنده , , Chourmouzios A and Saia، نويسنده , , Francesco and Lee، نويسنده , , Chi-hang and Degertekin، نويسنده , , Muzzafer and Hofma، نويسنده , , Sjoerd J and Sianos، نويسنده , , Georgios and McFadden، نويسنده , , Eugene and Smits، نويسنده , , Pieter C and van der Gi، نويسنده ,
Abstract :
The percutaneous treatment of coronary bifurcation stenoses is hampered by an increased rate of subsequent restenosis. The present study reports on the outcomes of a consecutive series of 58 patients with 65 de novo bifurcation stenoses treated with sirolimus-eluting stent implantation in both the main vessel and side branch. At 6 months, the incidence of major adverse cardiac events was 10.3% (1 death and 5 target lesion revascularizations) with no episodes of acute myocardial infarction or stent thrombosis.
